Skip to content

Valhi VHI Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Titanium Dioxide90%0.0%
Land Sales10%0.0%

By segment

See full
Component Products26%+23.8%

Other financials

Income statement

See full
Revenue$560.1M+4.0%
Gross profit$103.0M-15.9%
Net income$2.0M-88.2%
EPS (diluted)$0.07-88.1%

Balance sheet

See full
Cash & equivalents$193.7M-0.4%
Total debt$629.3M+2.9%
Total equity$1.0B-3.5%
Total assets$2.6B-5.3%

Cash flow

See full
Operating cash flow-$46.1M+70.4%
CapEx$10.6M-17.2%
Free cash flow-$56.7M+66.4%

Valuation

See full
Market cap$375.29M-15.1%
Enterprise value$810.89M-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin13.1%-8.7pp
Net margin-3.5%-9.0pp
FCF margin12.9%

Returns & leverage

See full
Return on equity-6.9%-18.7pp
Debt / equity0.6×0.0×
Current ratio3.2×+0.6×